12 Leukemia Clinical Trials in Anaheim, CA (2026)

Q: How do I join a clinical trial in Anaheim?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Anaheim research site will contact you.

Recruiting Leukemia Studies in Anaheim

NCT06692738Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the first-line (1L) treatment of patients with metastatic squam...

Anaheim, CAPHASE31,160 participantsAstraZeneca

View Study Details

NCT04389632Recruiting

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

This trial will look at a drug called sigvotatug vedotin (SGN-B6A) alone and with pembrolizumab, with or without chemotherapy, to find out whether it is safe for people who have solid tumors. It will ...

Anaheim, CAPHASE11,006 participantsSeagen, a wholly owned subsidiary of Pfizer

View Study Details

NCT07361510Recruiting

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

The purpose of this study is to evaluate the efficacy of Pumitamig versus Pembrolizumab in participants with previously untreated advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%....

Anaheim, CAPHASE3750 participantsBristol-Myers Squibb

View Study Details

NCT05254743Recruiting

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

The purpose of Part 1 of this study is to compare the efficacy and safety of pirtobruitinib (LOXO-305) to ibrutinib in participants with CLL/SLL; participants may or may not have already had treatment...

Anaheim, CAPHASE3737 participantsLoxo Oncology, Inc.

View Study Details

NCT06801834Recruiting

Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

The goal of this clinical study is to learn more about the study drug sacituzumab govitecan (SG; Trodelvy®; GS-0132; IMMU 132), versus standard of care (SOC) in participants with previously treated ex...

Anaheim, CAPHASE3695 participantsGilead Sciences

View Study Details

NCT04613596Recruiting

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

The Phase 2 portion of this study evaluates the efficacy and safety of MRTX849 monotherapy and in combination with pembrolizumab in cohorts of patients with advanced NSCLC with KRAS G12C mutation and ...

Anaheim, CAPHASE2626 participantsMirati Therapeutics Inc.

View Study Details

NCT04546399Recruiting

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

This phase II trial studies the effect of nivolumab in combination with blinatumomab compared to blinatumomab alone in treating patients with B-cell acute lymphoblastic leukemia (B-ALL) that has come ...

Anaheim, CAPHASE2461 participantsNational Cancer Institute (NCI)

View Study Details

NCT06104566Recruiting

Global Trial in APG2575 for Patients With CLL/SLL

This is a global multicenter, open label, randomized, registrational phase III study to investigate the efficacy and safety of lisaftoclax in combination with BTK inhibitors in CLL/SLL patients who pr...

Anaheim, CAPHASE3400 participantsAscentage Pharma Group Inc.

View Study Details

NCT06616584Recruiting

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

This phase II/III Expanded Lung-MAP treatment trial compares the effect of adding cemiplimab to docetaxel and ramucirumab versus docetaxel and ramucirumab alone in treating patients with non-small cel...

Anaheim, CAPHASE2378 participantsSWOG Cancer Research Network

View Study Details

NCT04269902Recruiting

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

This phase III trial compares early treatment with venetoclax and obinutuzumab versus delayed treatment with venetoclax and obinutuzumab in patients with newly diagnosed high-risk chronic lymphocytic ...

Anaheim, CAPHASE3247 participantsNational Cancer Institute (NCI)

View Study Details

NCT04205968Recruiting

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

This phase II trial studies how well ramucirumab and paclitaxel or the FOLFIRI regimen (leucovorin calcium, fluorouracil, and irinotecan hydrochloride) work in treating patients with small bowel cance...

Anaheim, CAPHASE294 participantsSWOG Cancer Research Network

View Study Details

NCT05642572Recruiting

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

This phase II Lung-MAP treatment trial test the combination of targeted drugs (capmatinib, osimertinib, and/or ramucirumab) in treating patients with non-small cell lung cancer that may have spread fr...

Anaheim, CAPHASE266 participantsSWOG Cancer Research Network

View Study Details

About Leukemia Clinical Trials in Anaheim

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 12 leukemia clinical trials recruiting participants in Anaheim, CA. These studies are seeking a combined 6,620 participants. Research is being sponsored by AstraZeneca, Seagen, a wholly owned subsidiary of Pfizer, Bristol-Myers Squibb and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in Anaheim — FAQ

Are there leukemia clinical trials in Anaheim?

Yes, there are 12 leukemia clinical trials currently recruiting in Anaheim, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Anaheim?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Anaheim research site will contact you about next steps.

Are clinical trials in Anaheim free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Anaheim studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 12 active trials in Anaheim are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated July 17, 2026 from ClinicalTrials.gov